Volume 9 Issue 1

A Reversal Agent in Time can Save Life- The Role of Idarucizumab in Dabigatran Associated Intracranial Bleed- A Case Report

Sreeja Namilakonda, Sindhu Priya Botta,and Jannu Nikshiptha
Dabigatran is a non-vitamin K antagonist oral anticoagulant (NOAC) whose widespread use for various indications has increased. Intracranial bleed in patients receiving dabigatran is a rare occurrence but can be fatal if reversible agent Idarucizumab is not administered immediately to reverse its effects.

Read More